Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

Strike while AI is hot: Rebuilding worker power for the age of AI
How worker power should be reanimated in the face of AI-driven labour market shocks.
The Europe agenda: Defence and security
In this period of geopolitical chaos, greater defence and security integration offer a fruitful way for the UK to deepen its relationship with Europe.
A tough hand: Why rising youth inactivity demands urgent action
On Thursday, new data will likely show the number of young people who will be out of education, employment or training (NEET) will surpass 1 million for the first time since 2013.